CHTN VUMC, Canada
Objective: VUMC-CHTN is primarily funded by the National Cancer Institute as a human surgical and autopsy remnant tissue procurement facility. Federal funds support less than 25% of operational costs with the other 75% of costs being recouped via services. The biorepository operates under a waiver of consent and also consents participants for use of remnant tissue and biofluid collection. Academic and commercial investigators with R&D protocols are encouraged to apply. We are not subsidized to support clinical trials.
|Registered Biobank Name||CHTN VUMC|
|Biobank Leader||Kerry Wiles|
|Email for biobank email@example.com|
|Principal Investigator||Dr. Mary Kay Washington|